Cover Image
Market Research Report

Novel Biomaterials for Medical Applications

Published by Frost & Sullivan Product code 553370
Published Content info 45 Pages
Delivery time: 1-2 business days
Back to Top
Novel Biomaterials for Medical Applications
Published: July 27, 2017 Content info: 45 Pages

Investing in Creating and Acquiring Innovative IP Is Vital to Current Competitive Landscape

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the synergies for partnership initiative within the industry, reviewing the roles and strategies of both existing and emerging participants.

Key Questions Answered by this RS:

  • 1. What is the role played by NPD (new product development) and R&D (research and development) initiatives in improving the overall adoption of biomaterials technologies across medical applications?
  • 2. What are the ongoing shifts in the healthcare needs which are largely driving research and development of biomaterials?
  • 3. What are the potential technology-enabled business opportunities that could be explored by existing competitors, and new players entering into the global industry for the biomaterials?
  • 4. Investments in hybrid biomaterials are expected to increase. What are the strategic priorities of existing and new participants in developing the global market?
Table of Contents
Product Code: D7D9

Table of Contents


  • 1.1. Scope of Research
  • 1.2. Research Methodology
  • 1.3. High Scope for Funding Research on Applications of PMMA, PEEK, and PLA
  • 1.4. Application of Biomaterials for Tissue Regeneration is an Actively Explored Area of Research Worldwide
  • 1.5. Success of Clinical Trials is Critical to Market Expansion Efforts of Leading Medical Technology Developers


  • 2.1. Four Major Class of Biomaterials Constitute Over 90% of the Global Market for Medical Applications of Biomaterials
  • 2.2. The Magnitude of Clinical Applications of Biomaterials is Very High for Cardiovascular Applications, Followed by Orthopedic
  • 2.3. Global Technology Development Initiatives Focus on Enhancing Functional Aspects and Durability of Medical Implants
  • 2.4. Commercial Attractiveness and Intensity of IP for Applications of Polymeric Biomaterials is High
  • 2.5. Favorable Economical and Technical Impact of Biomaterials across Various Medical Applications Drive Global R&D Efforts
  • 2.6. Polyethylene, Titanium Alloys, Silicone Rubber are Most Widely Used Biomaterials in Fabrication of Clinically Effective Medical implants
  • 2.7. Growing Demand for Newer Classes of Biomaterials Push Product Development Efforts across the Asia Pacific Region
  • 2.8. 3D Printing of Metals and Metal Alloys Enable Fabrication of Implants that Mimic Functions of Cancellous Bone Structures


  • 3.1. Clinical Trials Demonstrating Safety and Efficacy of Biomaterials Drive their Adoption across the Value Chain
  • 3.2. Hybrid Biomaterials that Combine Metals and Polymers Increase the Clinical Value of Medical Implants
  • 3.3. Demonstrating Clinical Value of Implants is Critical to Sustainable Adoption of Newer Classes of Biomaterials
  • 3.4. Metallic and Polymeric Biomaterials Exhibit High Potential for Investments from Venture Capital and Private Equity Firms
  • 3.5. Over 80% of Private Investments is Restricted to Technology Development and Clinical Evaluation of Biomaterials


  • 4.1. Technologies Available for Licensing are Very High for the Clinical Application of Polymeric & Natural Biomaterials
  • 4.2. Diversification Efforts of Technology Developers Focus on Enhancing Effectiveness and Durability of Medical Implants
  • 4.3. Magnitude of In-house Scientific Research is Very High for Polymeric Biomaterials Despite Low Availability of Research Grants


  • 5.1. The Ratio of Granted and Applied Patents Strike a Right Balance across Various Classes of Biomaterials Used in Medical Applications
  • 5.2. Spain and Germany are Jurisdictions with Key Patents Focusing on the Synthesis of Biomaterials for Tissue Regeneration Applications
  • 5.3. Cured-oil Hydrogel Biomaterials are Actively Explored as Effective Carriers in the Fabrication of Drug Delivery Systems
  • 5.4. 3D Printing Techniques and Materials are Actively Explored by Academic Research Groups for Fabricating Medical Implants
  • 5.5. Key Contacts
  • 5.5. Key Contacts (continued)
  • Legal Disclaimer


  • 6.1. The Frost & Sullivan Story
  • 6.2. Value Proposition: Future of Your Company & Career
  • 6.3. Global Perspective
  • 6.4. Industry Convergence
  • 6.5. 360° Research Perspective
  • 6.6. Implementation Excellence
  • 6.7. Our Blue Ocean Strategy
Back to Top